Our R&D programme is focused on the discovery and development of new molecules to treat chronic painful disorders. Our scientific team has a long-track experience in pain research. With this knowledge, we are currently developing two new molecular entities to provide precise innovative therapies for psoriatic pruritus and osteoarthritic pain